These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7384093)

  • 41. Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate.
    Scarano WR; Vilamaior PS; Taboga SR
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Nov; 288(11):1190-200. PubMed ID: 17031809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).
    Dionne CA; Camoratto AM; Jani JP; Emerson E; Neff N; Vaught JL; Murakata C; Djakiew D; Lamb J; Bova S; George D; Isaacs JT
    Clin Cancer Res; 1998 Aug; 4(8):1887-98. PubMed ID: 9717816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
    Johnson LE; Frye TP; Arnot AR; Marquette C; Couture LA; Gendron-Fitzpatrick A; McNeel DG
    Vaccine; 2006 Jan; 24(3):293-303. PubMed ID: 16115700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.
    Kaplan-Lefko PJ; Chen TM; Ittmann MM; Barrios RJ; Ayala GE; Huss WJ; Maddison LA; Foster BA; Greenberg NM
    Prostate; 2003 May; 55(3):219-37. PubMed ID: 12692788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A tumor-specific membrane phosphoprotein marker in human cell hybrids.
    Der CJ; Stanbridge EJ
    Cell; 1981 Nov; 26(3 Pt 1):429-38. PubMed ID: 7326746
    [No Abstract]   [Full Text] [Related]  

  • 46. The Pollard tumors.
    Pollard M
    Prog Clin Biol Res; 1980; 37():293-302. PubMed ID: 7384087
    [No Abstract]   [Full Text] [Related]  

  • 47. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
    Wikström P; Lindahl C; Bergh A
    Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. False elevations in prostate-specific antigen levels affecting patient management.
    Kummar S; Shafi NQ
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):599-601; discussion 602. PubMed ID: 16163243
    [No Abstract]   [Full Text] [Related]  

  • 49. Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.
    Noguchi M; Kobayashi K; Suetsugu N; Tomiyasu K; Suekane S; Yamada A; Itoh K; Noda S
    Prostate; 2003 Sep; 57(1):80-92. PubMed ID: 12886526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate.
    Ablin RJ; Soanes WA; Gonder MJ
    Urology; 1973 Sep; 2(3):276-9. PubMed ID: 4127037
    [No Abstract]   [Full Text] [Related]  

  • 53. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
    Degl'Innocenti E; Grioni M; Capuano G; Jachetti E; Freschi M; Bertilaccio MT; Hess-Michelini R; Doglioni C; Bellone M
    Cancer Res; 2008 Jan; 68(1):292-300. PubMed ID: 18172322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A monoclonal antibody that reacts with an antigen on both normal and malignant prostate cells].
    Dou L; Yu L; Xing N; Ding Y; Deng F; Guo Y
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):234-6, 44. PubMed ID: 11825376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological surveillance and -globulin.
    Ablin RJ
    Isr J Med Sci; 1973 Apr; 9(4):480-3. PubMed ID: 4122703
    [No Abstract]   [Full Text] [Related]  

  • 57. Analysis of development and differentiation with tumour cell glycoproteins.
    Koch G; Smith M
    Bioessays; 1985 Nov; 3(5):196-9. PubMed ID: 3842593
    [No Abstract]   [Full Text] [Related]  

  • 58. Cell-surface macromolecular and morphological changes related to allotransplantability in the TA3 tumor.
    Codington JF; Frim DM
    Biomembranes; 1983; 11():207-58. PubMed ID: 6338947
    [No Abstract]   [Full Text] [Related]  

  • 59. [Surface lectin receptors in the trypomastigote stage of Trypanosoma cruzi].
    Katzin AM; Lajmanovich S; González Cappa SM
    Medicina (B Aires); 1980; 40 Suppl 1():85-90. PubMed ID: 7005616
    [No Abstract]   [Full Text] [Related]  

  • 60. Lectin receptors on rod and cone membranes.
    Bridges CD; Fong SL
    Photochem Photobiol; 1980 Oct; 32(4):481-6. PubMed ID: 6969893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.